Feed aggregator
RAS(ON) inhibitor doubles median overall survival in results of phase 3 trial for patients with metastatic pancreatic cancer
Categories: Content
ASCO: Tile-based radiation therapy lowers risk of recurrence in brain metastases
Categories: Content